Scarica l'app Stockscreener
0.7223
7.12%
-0.0554
Pre-mercato:
.74
0.0177
+2.45%
Talphera Inc Borsa (TLPH) Ultime notizie
Risk Recap: Will Talphera Inc stock hit new highs in YEAR - baoquankhu1.vn
TALPHERA (TLPH) CEO uses 9,938 shares to cover RSU tax withholding - stocktitan.net
Talphera (TLPH) CFO surrenders shares to cover RSU tax bill - stocktitan.net
TALPHERA, INC. (TLPH) CMO surrenders 2,118 shares for RSU taxes - stocktitan.net
[Form 4] TALPHERA, INC. Insider Trading Activity - stocktitan.net
[EFFECT] TALPHERA, INC. SEC Filing - stocktitan.net
Trend Recap: Does Talphera Inc stock reflect fundamentalsMarket Growth Summary & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Talphera (NASDAQ: TLPH) registers resale of 639,931 shares and 6.4M warrant shares - stocktitan.net
Will Talphera Inc benefit from current market trends2026 Closing Moves & Daily Oversold Bounce Ideas - baoquankhu1.vn
Maxim Group Maintains Talphera(TLPH.US) With Buy Rating, Maintains Target Price $3 - 富途牛牛
Rate Cut: Why is Talphera Inc stock going down2026 Institutional Moves & Weekly Watchlist of Top Performers - baoquankhu1.vn
TLPH Should I Buy - Intellectia AI
Fed Meeting: Is Talphera Inc stock overvalued or fairly pricedQuarterly Portfolio Summary & Trade Opportunity Analysis Reports - baoquankhu1.vn
Dow Update: Whats the profit margin of Talphera IncGlobal Markets & Technical Pattern Based Buy Signals - baoquankhu1.vn
Talphera files prospectus for resale of up to 30.9M shares by selling stockholders - MSN
Aug EndMonth: Is Talphera Inc a top pick in the sectorMarket Sentiment Review & Verified Short-Term Trading Plans - baoquankhu1.vn
Angotti buys Talphera (TLPH) shares worth $124,999 By Investing.com - Investing.com Australia
Angotti buys Talphera (TLPH) shares worth $124,999 - Investing.com
Talphera (TLPH) CEO boosts stake with 213,310-share open-market buy - Stock Titan
Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026 - Bitget
Talphera (TLPH) registers resale of up to 7.04M shares from private placement - stocktitan.net
Talphera (TLPH) Reports Progress in Nafamostat Study and Financi - GuruFocus
Talphera: Q4 Earnings Snapshot - theheraldreview.com
Talphera, Inc. (Formerly AcelRx) 2025 Annual Report: Business Overview, Key Risks, and Regulatory Challenges in Specialty Pharmaceuticals - Minichart
Talphera Q4 2025 & Investor Day Earnings Call Transcript - MarketBeat
Talphera Inc. Q4 & Fiscal 2025 Financial Results: Revenue & Net Loss ReportNews and Statistics - IndexBox
[10-K] TALPHERA, INC. Files Annual Report - Stock Titan
Talphera 2025 10-K: Revenue $0.028M, Net Loss $14.3M - tradingview.com
TLPH: Net loss increased to $14.3M in 2025; urgent capital needs and Nasdaq delisting risk persist - TradingView
Talphera Inc (TLPH) Reports Q4 Earnings - AlphaStreet
Earnings call transcript: Talphera Inc. Q4 2025: Stock Declines Amid Study Delays By Investing.com - Investing.com South Africa
Earnings call transcript: Talphera Inc. Q4 2025: Stock Declines Amid Study Delays - Investing.com India
Talphera, Inc. (NASDAQ: TLPH) 2026 Financial Results and Company Information Overview - Minichart
Talphera, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 - MarketScreener
Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - Bitget
Talphera: Fourth Quarter Financial Results Overview - Bitget
TLPH: 50% enrollment milestone reached in NEPHRO CRRT study; $20.4M cash at year-end 2025 - TradingView
Rate Hike: Can Talphera Inc grow without external fundingTake Profit & Comprehensive Market Scan Reports - baoquankhu1.vn
Talphera, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
TLPH PE Ratio & Valuation, Is TLPH Overvalued - Intellectia AI
Talphera outlines accelerated NEPHRO CRRT study timeline with completion targeted by end of 2025, supported by new site activations and $14.8M financing - MSN
Street Watch: Can Talphera Inc keep up with sector leaders2026 Trends & Capital Efficiency Focused Strategies - baoquankhu1.vn
Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026 - ChartMill
Nantahala Capital-linked holders in Talphera (TLPH) acquire 4,266,211 pre-funded warrants - Stock Titan
Talphera, Inc. (formerly AcelRx Pharmaceuticals) Files Form 8-K – Company Details and SEC Filing Information - Minichart
Talphera (NASDAQ: TLPH) adds $4.1M in third private placement - Stock Titan
Talphera Receives Nasdaq Notice on Minimum Bid Price - The Globe and Mail
Talphera, Inc. 8-K SEC Filing: Company Information, Address, NASDAQ Listing & Key Details (March 11, 2026) - Minichart
Talphera Received Notice of Noncompliance - TradingView
Talphera (NASDAQ: TLPH) faces Nasdaq minimum bid-price deficiency notice - Stock Titan
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):